Streetbeat News

Stock Prices

FXY

The Japanese yen has plummeted to 160 against the dollar, its lowest level since December 1986, prompting speculation about potential intervention by the Bank of Japan. The yen's depreciation is tracked by the Invesco CurrencyShares Japanese Yen Trust (NYSE: FXY). Analysts suggest that the Bank of Japan may intervene depending on upcoming economic data and the speed of yen depreciation.

Portfolio Pulse from Piero Cingari

June 26, 2024 | 3:26 pm

NVO

Novo Nordisk shares are trading lower after the company stopped its Ocedurenone Clarion-CKD trial.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 3:26 pm

RPD

Activist investor Jana Partners is urging cybersecurity firm Rapid7 to sell itself, according to a report by the Wall Street Journal. This move could potentially lead to a sale of the company, impacting its stock price.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 3:26 pm

NVO

Novo Nordisk has stopped the Ocedurenone Clarion-CKD trial after it failed to meet its primary endpoint. The company will recognize an impairment loss of around DKK 5.7 billion related to the intangible asset Ocedurenone in Q2 of 2024, which is expected to negatively impact operating profit growth by around 6 percentage points at CER in 2024.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 3:25 pm

TSLA

Tesla Inc (NASDAQ:TSLA) shares are trading higher following a bullish analyst initiation from Stifel. Analyst Stephen Gengaro initiated coverage with a Buy rating and a $265 price target, citing Tesla's potential for robust multi-year growth driven by new models, AI-based Full Self-Driving, and other initiatives. Despite near-term risks, Tesla's strong balance sheet and free cash flow are expected to support continued growth.

Portfolio Pulse from Adam Eckert

June 26, 2024 | 3:23 pm

MRNA

Moderna shares are trading lower after the company's RSV vaccine showed 50% efficacy.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 3:22 pm

DMAC

DiaMedica Therapeutics shares are trading higher following the announcement of an $11.8 million private placement, issuing 4.720 million shares at $2.50 per share.

Portfolio Pulse from Benzinga Newsdesk

June 26, 2024 | 3:19 pm

DAKT

Daktronics, Inc. (NASDAQ:DAKT) shares surged following strong Q4 FY24 results, with sales hitting a record $215.9 million, beating the consensus of $186.19 million. Despite an EPS miss, the company saw significant growth in new orders and operating income. CEO Reece Kurtenbach outlined priorities for a broad digital transformation in fiscal 2025.

Portfolio Pulse from Lekha Gupta

June 26, 2024 | 3:17 pm

VRT

Deep-pocketed investors are showing significant bearish sentiment towards Vertiv Holdings (NYSE:VRT) through options trading. Benzinga's options scanner detected 19 extraordinary options activities, with 52% of the sentiment being bearish. The stock price is currently down 5.15% at $87.0, and RSI indicators suggest it may be approaching oversold territory. Analysts have an average target price of $105.0.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 3:16 pm

SRPT

Recent options activity for Sarepta Therapeutics (NASDAQ:SRPT) shows a bearish stance among large investors, with 50% of trades being bearish. The trades include 5 puts totaling $374,000 and 9 calls totaling $1,862,920. Analysts have mixed ratings, with price targets ranging from $170 to $230.

Portfolio Pulse from Benzinga Insights

June 26, 2024 | 3:16 pm